Bionano Genomics, Inc. (BNGO) Net margin 2017–2025
Bionano Genomics, Inc. (BNGO) net profit margin by fiscal year — reported net income divided by reported revenue.
-92.6%FY2025 · since FY2017: -245.8% → -92.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -92.6% | +271.4 pp |
| FY2024 | -364.0% | +279.8 pp |
| FY2023 | -643.7% | -166.8 pp |
| FY2022 | -476.9% | -74.1 pp |
| FY2021 | -402.8% | +80.6 pp |
| FY2020 | -483.4% | -189.1 pp |
| FY2019 | -294.3% | -140.2 pp |
| FY2018 | -154.1% | +91.7 pp |
| FY2017 | -245.8% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice